Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial

PURPOSE: A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea. MATERIALS AND METHODS: The TIV was administered to 43 healthy male adults. Subjects with high pre-existing titers...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Kyuri, Han, Seunghoon, Hong, Taegon, Jeon, Sangil, Paek, Jeongki, Kang, Jin Han, Yim, Dong-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011266/
https://www.ncbi.nlm.nih.gov/pubmed/27593862
http://dx.doi.org/10.3349/ymj.2016.57.6.1354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011266/
https://www.ncbi.nlm.nih.gov/pubmed/27593862
http://dx.doi.org/10.3349/ymj.2016.57.6.1354

Ejemplares similares